Compagnie Lombard Odier S Cm A Novartis Ag Transaction History

Compagnie Lombard Odier S Cm A

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$79.7 - $88.13 $0 - $0	0 Closed	0 $0
Q3 2021 Oct 28, 2021	SELL	$81.78 - $95.14 $24,534 - $28,542	-300 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$78.07 - $94.43 $23,420 - $28,329	300 New	300 $28,000
Q2 2020 Aug 14, 2020	SELL	$80.93 - $91.1 $0 - $0	0 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$70.67 - $99.01 $35,335 - $49,505	-500 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$84.35 - $95.37 $1.32 Million - $1.5 Million	-15,700 Reduced 96.91%	500 $47,000
Q2 2019 Aug 14, 2019	BUY	$75.4 - $92.8 $37,700 - $46,400	500 Added 3.18%	16,200 $1.48 Million
Q3 2018 Nov 13, 2018	BUY	$66.94 - $77.43 $1.02 Million - $1.18 Million	15,300 Added 3825.0%	15,700 $1.35 Million
Q2 2018 Aug 10, 2018	SELL	$64.91 - $73.36 $9,736 - $11,004	-150 Reduced 27.27%	400 $30,000
Q3 2017 Nov 14, 2017	SELL	$74.14 - $77.27 $13,345 - $13,908	-180 Reduced 24.66%	550 $47,000
Q2 2017 Aug 14, 2017	BUY	N/A	730	730 $61,000

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Compagnie Lombard Odier S Cm A, based on Form 13F filings with the SEC.

Stay updated on Compagnie Lombard Odier S Cm A with notifications on news.